Prevalnec of progression

Kirjallisuutta

1. Leske MC, Heijl A, Hussein M ym. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003;121:48-56 «PMID: 12523884»PubMed
2. Pohjanpelto P. Long-term prognosis of visual field in glaucoma simplex and glaucoma capsular. Acta Ophthalmol (Copenh) 1985;63:418-23 «PMID: 4050362»PubMed
3. Mikelberg FS, Schulzer M, Drance SM ym. The rate of progression of scotomas in glaucoma. Am J Ophthalmol 1986;101:1-6 «PMID: 3942160»PubMed
4. Airaksinen PJ, Tuulonen A, Alanko HI. Rate and pattern of neuroretinal rim area decrease in ocular hypertension and glaucoma. Arch Ophthalmol 1992;110:206-10 «PMID: 1736869»PubMed
5. Rasker MT, van den Enden A, Bakker D ym. Rate of visual field loss in progressive glaucoma. Arch Ophthalmol 2000;118:481-8 «PMID: 10766133»PubMed
6. Katz J, Gilbert D, Quigley HA ym. Estimating progression of visual field loss in glaucoma. Ophthalmology 1997;104:1017-25 «PMID: 9186444»PubMed
7. The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study: 7. Results. Glaucoma Laser Trial Research Group. Am J Ophthalmol 1995;120:718-31 «PMID: 8540545»PubMed
8. Girkin CA, Emdadi A, Sample PA ym. Short-wavelength automated perimetry and standard perimetry in the detection of progressive optic disc cupping. Arch Ophthalmol 2000;118:1231-6 «PMID: 10980768»PubMed
9. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 1998;126:498-505 «PMID: 9780094»PubMed
10. Quigley HA, Tielsch JM, Katz J ym. Rate of progression in open-angle glaucoma estimated from cross-sectional prevalence of visual field damage. Am J Ophthalmol 1996;122:355-63 «PMID: 8794708»PubMed
11. Chen PP, Park RJ. Visual field progression in patients with initially unilateral visual field loss from chronic open-angle glaucoma. Ophthalmology 2000;107:1688-92 «PMID: 10964831»PubMed
12. Linner E. Ocular hypertension. A five-year study of the total population in a Swedish tow, Skövde. Glaucoma, Symp. Tutzing Castle, 1966, pp. 187-94 (Karger, Basel/New York 1967)
13. Linnér E. Ocular hypertension. I. The clinical course during ten years without therapy. Aqueous humour dynamics. Acta Ophthalmol (Copenh) 1976;54:707-20 «PMID: 990020»PubMed
14. Lundberg L, Wettrell K, Linnér E. Ocular hypertension. A prospective twenty-year follow-up study. Acta Ophthalmol (Copenh) 1987;65:705-8 «PMID: 3434236»PubMed
15. Bengtsson B. Manifest glaucoma in the aged I: occurrence nine years after a population survey. Acta Ophthalmol (Copenh) 1981;59:321-31 «PMID: 7324880»PubMed
16. Quigley HA, Enger C, Katz J ym. Risk factors for the development of glaucomatous visual field loss in ocular hypertension. Arch Ophthalmol 1994;112:644-9 «PMID: 8185522»PubMed
17. Heijl A, Bengtsson B. Diagnosis of early glaucoma with flicker comparisons of serial disc photographs. Invest Ophthalmol Vis Sci 1989;30:2376-84 «PMID: 2807794»PubMed
18. Epstein DL, Krug JH Jr, Hertzmark E ym. A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects. Ophthalmology 1989;96:1460-7 «PMID: 2685707»PubMed
19. Georgopoulos G, Andreanos D, Liokis N ym. Risk factors in ocular hypertension. Eur J Ophthalmol 1997;7:357-63 «PMID: 9457459»PubMed